I lost over 3 stone on Mounjaro and went from a size 18 to a 10 - here's the terrifying truth about what REALLY happened after my last jab: CLAUDIA CONNELL
After six months on weight-loss injections, it's time to stab myself in the stomach with Mounjaro for the final time, something I do with mixed feelings: triumph at all I've achieved and nerves about what lies ahead.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
20 minutes ago
- Daily Mail
Autopsy for college football player who passed away suddenly at 18 reveals stunning cause of death
The cause of death for a University of Cincinnati freshman offensive lineman who passed away in April at his residence in Ohio has been revealed. Jeremiah Kelly - who was set to play his first season of college football for the Cincinnati Bearcats this fall - died from cardiac hypertrophy, according to documents obtained by ESPN. Cardiac hypertrophy is a disease which enlarges the heart muscle, which sometimes leads to heart failure or sudden cardiac arrest. Kelly's mother, Chiniqua Kelly, told the outlet that her son wore a heart monitor during workouts and that he'd been relaxing at his residence the day before his passing. She added that Jeremiah was her 'healthiest' child and he did not have any issues before his death. 'The Cincinnati football program and athletics department continue to mourn Jeremiah's passing,' a Cincinnati spokesperson said to ESPN. 'He is deeply missed by all of us.' The team spokesperson also said that Kelly passed a physical examination mandated by the NCAA before he participated in team activities. Kelly enrolled at Cincinnati early and was on campus for the team's spring practices to prepare for the upcoming season. 'The Bearcats football family is heartbroken by the sudden loss of this outstanding young man,' Cincinnati head coach Scott Satterfield said in April. 'In the short time Jeremiah has spent with our team, he has made a real impact, both on the field and in our locker room. 'My prayers are with the Kelly family and those who had the pleasure of knowing Jeremiah.' 247Sports rated Kelly as a three-star recruit to the school as a part of their Class of 2025. Cincinnati's recruiting class was ranked 14th out of 16 in the Big XII and 61st in the nation. Kelly - a native of Avon, Ohio - chose Cincinnati over an offer from the University of Akron. In high school, Kelly helped lead his team to a perfect 16-0 record and a state championship in his senior year.
Daily Mail
20 minutes ago
- Daily Mail
Scientists can now reveal when you'll die with a simple test
A simple brain scan in your 40s can reveal how long you may have to live, depending on how fast your body is aging. Researchers from Duke University have discovered that MRI brain imaging during midlife can accurately determine the pace someone is aging biologically, helping doctors to predict the onset of several diseases including Alzheimer's. Biological aging refers to how quickly your body is aging compared to your actual age, which can affect your health and how long you might live. In this study, the researchers tied faster aging to physical changes in the brain that are usually seen in elderly adults, especially those experiencing cognitive decline. Scientists developed a tool called the DunedinPACN, which takes a single scan and calculates the patient's 'Pace of Aging' by analyzing factors like surface area, gray matter volume, and the size of specific brain regions like the hippocampus. Researchers trained their new tool on the brain scans of 860 people in the Dunedin Study, giving the device its name. The results revealed that people determined to be aging at the fastest rates were 18 percent more likely to be diagnosed with a chronic disease within the next few years. Moreover, these 'fast agers' were 40 percent more likely to die within that timeframe compared to those aging more slowly. Ahmad Hariri, a professor of psychology and neuroscience at Duke, said: 'What's really cool about this is that we've captured how fast people are aging using data collected in midlife and it's helping us predict diagnosis of dementia among people who are much older.' DunedinPACN revealed that people whose brain scans showed faster aging did worse on memory and thinking tests and had more shrinkage in the hippocampus, a key region tied to memory. Smaller hippocampal volume was linked to faster cognitive decline, while larger ventricle volumes (fluid-filled spaces in the brain) was associated with worse health after middle age. Faster agers were also more likely to develop health problems like frailty, heart attacks, lung disease, or strokes later in life. 'The way we age as we get older is quite distinct from how many times we've traveled around the sun,' Hariri said in a statement. The study author added that several computer algorithms have been created to serve as so-called 'aging clocks' but these programs typically rely on data from people of all ages, taken at a single point in their lives. The new study, published in the journal Nature Aging, focused on participants at age 45, creating more uniformity in the results. A software called FreeSurfer was used to process the brain scans and measure 315 different brain features, including cortical thickness, how thick the outer layer of the brain (the cortex) is. Thinner areas of the cortex might suggest faster aging or wear and tear. 'The link between aging of the brain and body are pretty compelling,' Hariri added. The professor added that the connection between Pace of Aging and dementia was just as strong across different racial and economic backgrounds in the study. Specifically, the Dunedin Study included participants who were low-income and non-White, and lived everywhere from Latin America to the UK. 'It seems to be capturing something that is reflected in all brains,' Hariri said. The MRI scans also measured factors like gray-white matter signal intensity ratio, which compares how bright gray matter looks to white matter (the brain's wiring that connects different areas). A change in this ratio can show differences in brain tissue health, like how well the brain is holding up as you age. Researchers noted that the size of a person's hippocampus can also shrink with age or from diseases like Alzheimer's. So, a smaller hippocampus might signal faster aging or higher dementia risk, especially among people who are only in their 40s. Meanwhile, Ventricles, the fluid-filled spaces in the brain that help cushion it, often get bigger when the brain tissue around them is shrinking - another sign of advanced aging or brain health issues. The Duke team then examined the brain scans of 624 people ranging in age from 52 to 89 who took part in the North American study of risk for Alzheimer's disease. They determined that the fastest agers were 60 percent more likely to develop dementia in their later years. Fast agers also began to suffer from memory and thinking issues sooner than those who found to be aging slower. These slow agers had brains that looked younger and healthier than expected, like having a 30-year-old's brain in a 45-year-old body. Their brains featured a thicker cortex or larger hippocampus and showed fewer signs of wear and tear. They were also less likely to develop chronic diseases, meaning they typically had longer lifespans than the fast agers. When the team saw the results, 'our jaws just dropped to the floor,' Hariri said.
Daily Mail
20 minutes ago
- Daily Mail
Scientists discover new form of condition suffered by 38million Americans... putting even more at risk
A possible third type of diabetes that could potentially impact nearly 2million Americans has been discovered. An international team of researchers found that a specific subset of people with type 1 diabetes — which affects about 1.8million Americans — may actually have an entirely new form of the disease that is not caused by the immune system. Type 1 diabetes affects 8.4million people globally and is caused by the immune system misfiring and destroying cells that help to control blood sugar. But now scientists in the US and UK say they have detected a new variant of the disease in people of sub-Saharan African descent that does not appear to be linked to the immune system. Their analysis of nearly 900 people with childhood-onset type 1 diabetes from three African countries revealed that only about 33 percent had the characteristic antibodies — proteins made by the immune system that attack cells used to control blood sugar — seen in type 1 diabetics. The remaining 66 percent previously diagnosed with type 1 diabetes did not test positive for these antibodies, suggesting they had a new variant of the disease. Revealing the findings, researchers said it could pave the way for new treatments for the disease to boost health and life expectancy, with type 1 diabetics dying about a decade earlier than their peers on average. More than 38.4million Americans have diabetes, with the vast majority — around 37million — having type 2 diabetes, a chronic condition where the body can't use the insulin it produces, a hormone used to control blood sugar, leading to high blood sugar levels. This differs from type 1 diabetes, which is caused by the immune system attacking islet cells that make insulin, causing blood sugar levels to spike. The disease is typically diagnosed by testing the blood for characteristic antibodies against islet cells, indicating the disease. In the study, a similar analysis was repeated on 107 Americans of sub-Saharan African background with type 1 diabetes. It found 55 percent of them tested negative for typical type 1 diabetes antibodies. Writing in the study, the team led by the UK's University of Exeter said: 'These findings support the common existence of a non-autoimmune, insulin-deficient subtype of diabetes among children and young adults with diabetes in sub-Saharan Africa. '[This] is different from classic autoimmune type 1 diabetes, and does not have features consistent with type 2 diabetes or malnutrition-associated diabetes. 'Therefore, alternative causes must be considered in this group of individuals.' Researchers are not sure what may cause this version of diabetes, but said it might be linked to malnutrition in early life, which could cause cells to become less sensitive to the hormone insulin, which helps to control blood sugar. They also suggested it may be due to certain genetic variations in sub-Saharan African populations that are not present in white groups. Of those diagnosed with type 1 diabetes in the US, an estimated nearly 10 percent — or 167,000 — are black. It is not clear what proportion of these can trace their roots back to Sub-Saharan Africa. For the first part of the study, participants were recruited from Cameroon, Uganda and South Africa. About half were female, all were black, and participants were diagnosed with diabetes at the age of 15 years on average. They all also had a healthy body weight. For participants from Cameroon and Uganda, blood samples were collected from patients who had visited private or public hospitals between 2019 and 2022. These were analyzed for the presence of antibodies that would indicate the presence of type 1 diabetes. To expand the dataset, the researchers also included participants from South Africa who had their blood tested for the same antibodies between 2007 and 2015. A total of 312 participants, or 35 percent, tested positive for the antibodies, while the remaining 582 tested negative. Next, the researchers extracted data from the SEARCH database, which collects data on young people diagnosed with type 1 diabetes in the US. They extracted information on 3,000 participants, including 2,602 from a white ethnic background and 429 from a black ethnic background. Among the 107 recorded as being from a Sub-Saharan African background by the database, 55 percent or 59 participants did not test positive for the typical antibodies. And among those from a black background, 65 participants or 15 percent tested negative for the antibodies. The researchers said a similar pattern was not detected among those from a white ethnic background. Dr Dana Dabelea, an epidemiologist at the University of Colorado and co-author of the study, said: 'The identification of this type 1 diabetes in Sub-Saharan African populations and among individuals of African ancestry in the US suggests a potential ancestral or genetic link. 'These findings highlight the need to consider alternative etiologies in this group and a deeper understanding of the underlying mechanisms may provide important insights for future prevention and treatment strategies.'
